Acetylcholinesterase (AChE) inhibitors are widely used for the symptomatic treatment of Alzheimer’s disease and other dementias because the inhibition of AChE slows the hydrolysis of acetylcholine and increases choline levels, which improves cognitive function. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.